Condition Overview

Metabolic Liver Health

For people managing fatty liver findings alongside their own physician.

Book a Consultation Am I a Candidate?

or call (818) 938-9023

Cellular artwork for Metabolic Liver Health Personalized review, grounded in your health history.
Overview

Understanding NAFLD and fatty liver

Metabolic dysfunction-associated steatotic liver disease, previously called nonalcoholic fatty liver disease, occurs when excess fat builds up in the liver. Some people have little inflammation, while others develop inflammation, scarring, or more advanced liver disease. It often overlaps with weight, diabetes, cholesterol, and cardiovascular risk.

Diagnosis and monitoring belong with a primary care clinician, gastroenterologist, or hepatologist. Established management may include nutrition, activity, weight reduction when appropriate, metabolic risk management, and treatment of complications. Cellular and regenerative approaches remain experimental and are not a substitute for laboratory testing, imaging, or specialist care.

Our consultation reviews your diagnosis, recent liver information, medication, metabolic health, and goals. If you have recent liver enzyme results, a FibroScan or elastography reading, or recent imaging, have them to hand, because they are the difference between a general conversation and a useful one. A licensed provider explains the limits of available evidence and decides whether any supportive assessment is appropriate. No cell-derived or regenerative product is approved to treat liver fibrosis or any stage of liver disease.

Some liver problems need urgent attention rather than a consultation. Vomiting blood, black or tarry stools, yellowing of the skin or eyes, new confusion or drowsiness, or a swollen and painful abdomen need emergency care now: call 911 or go to an emergency department.

Possibilities

Potential Benefits

A liver-health consultation may help you:

  • A structured review of your liver findings, your metabolic risk factors, and your current care
  • A clear account of what cell-based research has and has not established in fatty liver disease
  • Screening for liver and metabolic factors that may affect eligibility
  • Questions to discuss with your hepatologist or primary care clinician
  • A realistic next step, which for advanced fibrosis or cirrhosis is a return to hepatology care
Considerations

Who May Benefit

A liver-health assessment may make sense for people including:

  • Adults with MASLD or NAFLD documented by a clinician
  • People already addressing metabolic and cardiovascular risk factors
  • Individuals under primary care, gastroenterology, or hepatology follow-up
  • People willing to share recent liver enzyme results, elastography or FibroScan readings, and imaging
  • Adults seeking a realistic explanation of experimental research
Related Care

Therapies a Provider May Consider

Every option is reviewed individually after your history, current care, and goals are understood.

  • Physician Guided

Exosome Therapy

Exosome therapy works with the signaling vesicles your cells already use to communicate. Studied for recovery, skin quality and healthy aging, and always planned by a licensed provider.

Learn More about Exosome Therapy
  • Physician Guided

NAD+ Therapy

NAD+ is the coenzyme your cells use to turn food into energy, and levels fall with age. A leading choice for support with energy, mental clarity and recovery.

Learn More about NAD+ Therapy
  • Physician Guided

MUSE Cell Therapy

A stress enduring cell type able to develop into many tissue types. Explored for healthy aging, recovery and whole body cellular wellness, always guided by clinical review.

Learn More about MUSE Cell Therapy
  • Physician Guided

Stem Cell Therapy

The body's own building and repair cells, and the foundation of regenerative medicine. Explored for recovery, mobility and healthy aging through physician guided planning.

Learn More about Stem Cell Therapy
Evidence

What the Research Looks At

MASLD and NAFLD have established evaluation and risk-management pathways. Regenerative approaches remain experimental and do not replace liver or metabolic care. These references provide condition guidance, regulatory context, and registered-study information.

  1. Definition and Facts of NAFLD and NASH National Institute of Diabetes and Digestive and Kidney Diseases, NIH
  2. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes U.S. Food and Drug Administration
  3. Registered clinical trials related to MASLD ClinicalTrials.gov, U.S. National Library of Medicine
Your Next Step

Start With an Assessment

Every visit begins with a consultation and a medical screening. A licensed provider decides what, if anything, is appropriate for you.

Book a Consultation

or call (818) 938-9023

Terms you may hear when discussing liver health

The names in this area changed recently, and the tests have their own shorthand. These are the terms that appear on the results a provider here will ask to see.

  • MASLD. Metabolic dysfunction-associated steatotic liver disease, the current name for what was called nonalcoholic fatty liver disease, or NAFLD. Both names describe fat build-up in the liver linked to metabolic risk factors rather than alcohol.
  • MASH. Metabolic dysfunction-associated steatohepatitis, previously NASH: the form in which fat is accompanied by inflammation and liver cell injury. It carries a higher risk of progressing to scarring.
  • ALT and AST. Liver enzymes measured in a standard blood panel. Raised levels suggest liver cell injury but do not by themselves show how much scarring is present.
  • Elastography and fibrosis stage. Elastography, often done with a FibroScan device, measures liver stiffness without a biopsy to estimate scarring. The result is expressed as a fibrosis stage from F0, no scarring, to F4, cirrhosis, and it is the number that changes what should happen next.

A licensed provider reviews your diagnosis, recent liver information, medication, metabolic health and goals before deciding whether any supportive assessment is appropriate alongside your gastroenterologist or hepatologist. Nothing offered is a treatment for liver disease at any stage.

Related conditions in this care area: Healthy Aging and General Wellness and Sarcopenia and Age-Related Muscle Loss. Because fatty liver overlaps with weight, diabetes and cholesterol, see also Type 2 Diabetes and Insulin Resistance and Metabolic Syndrome. Back to Longevity and Vitality.

Metabolic Liver Health

Frequently Asked Questions

No. Nothing offered here is a cure or an approved treatment for MASLD or NAFLD. The purpose of the consultation is to review your history, explain the limits of current research, and decide whether any supportive assessment is appropriate.
No. Liver testing, imaging, monitoring, and any prescribed medication stay with your primary care clinician, gastroenterologist, or hepatologist. This consultation sits alongside that care and does not replace it.
You share intake information and any recent liver and metabolic results, then complete a medical screening. A licensed provider reviews your diagnosis, your current care, and your goals. Only after that review can the provider decide whether any next step is appropriate, and established management of your metabolic risk factors remains the part with the evidence behind it.
A licensed provider makes that decision after reviewing your history and screening information. Not everyone is eligible, and being told that no further step is appropriate is a normal outcome of an honest assessment.
Hitech Regen serves Southern California. Availability and suitability are discussed during the consultation before any visit is scheduled.
Cost is discussed after a licensed provider determines whether anything is appropriate to consider. We do not quote a condition-specific plan before the assessment.
Your hepatologist, gastroenterologist or primary care physician. We do not manage liver disease and we do not change prescribed medication. Anything discussed here sits alongside the care they provide.
It is relevant, and it is one of the things a licensed provider will want documented. Bring recent imaging, elastography or blood results your own clinician has ordered.
We make no claim of that kind. Nothing offered here is a cure and no product we work with is FDA approved for liver disease.
Yes, and be straightforward about it at intake. It is part of the medical screening and it is directly relevant to what your own clinician is managing.
Book a Consultation